UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000034908
Receipt number R000039801
Scientific Title Aerobic exercise for cognitive impairment in schizophrenia: A systematic review and meta-analysis
Date of disclosure of the study information 2018/11/17
Last modified on 2022/05/16 15:35:05

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Aerobic exercise for cognitive impairment in schizophrenia: A systematic review and meta-analysis

Acronym

Aerobic exercise for cognitive impairment in schizophrenia: A systematic review and meta-analysis

Scientific Title

Aerobic exercise for cognitive impairment in schizophrenia: A systematic review and meta-analysis

Scientific Title:Acronym

Aerobic exercise for cognitive impairment in schizophrenia: A systematic review and meta-analysis

Region

Japan


Condition

Condition

schizophrenia

Classification by specialty

Psychiatry Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effects of (aerobic exercise, AE) on cognition of schizophrenia and to examine the methods of AE for enhancing cognitive functioning

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

cognitive functioning

Key secondary outcomes



Base

Study type

Others,meta-analysis etc


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

controlled trials that evaluated the effects of aerobic exercise on cognition of schizophrenia

Key exclusion criteria

studies not met inclusion criteria

Target sample size

300


Research contact person

Name of lead principal investigator

1st name Takeshi
Middle name
Last name Shimada

Organization

Medical Corporation Seitaikai Mental Support Soyokaze Hospital

Division name

Department of Rehabilitation

Zip code

3860401

Address

3057-1, Shiogawa, Ueda, Nagano, Japan

TEL

0268-35-0305

Email

ot@seitaikai.or.jp


Public contact

Name of contact person

1st name Takeshi
Middle name
Last name Shimada

Organization

Medical Corporation Seitaikai Mental Support Soyokaze Hospital

Division name

Department of Rehabilitation

Zip code

3860401

Address

3057-1, Shiogawa, Ueda, Nagano, Japan

TEL

0268-35-0305

Homepage URL


Email

ot@seitaikai.or.jp


Sponsor or person

Institute

Medical Corporation Seitaikai Mental Support Soyokaze Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Medical Corporation Seitaikai Mental Support Soyokaze Hospital

Address

3057-1, Shiogawa, Ueda, Nagano, Japan

Tel

0268-35-0305

Email

ot@seitaikai.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 11 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

593

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 11 Month 07 Day

Date of IRB

2018 Year 11 Month 17 Day

Anticipated trial start date

2018 Year 11 Month 17 Day

Last follow-up date

2022 Year 05 Month 16 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Two independent authors conducted an electronic database search of Ovid MEDLINE, Cochrane Central Register of Controlled Trials, Health Technology Assessment Database, PsycINFO, Web of Science from inception to November 2018. The search terms used were: ("schizophrenia spectrum and other psychotic disorders"[Mesh]) and ("exercise"[Mesh] or "physical fitness"[Mesh] or "resistance training"[Mesh]) and ("cognition"[Mesh] or "cognitive science"[Mesh]). The reference lists of retrieved articles were also searched.


Management information

Registered date

2018 Year 11 Month 16 Day

Last modified on

2022 Year 05 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039801


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name